DeepBiome Therapeutics Company
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform. The company's drug discovery platform leverages deep learning, microbiome, and synthetic biology technologies, enabling drug companies to release the therapeutic power of the microbiome. It was founded in 2017 and is based in Allston, Massachusetts.
Technology:
AI-driven Drug Target Identification
Industry:
BioPharma AI
Founded Date:
2017
Employee Number:
7
Headquarters:
Allston, Massachusetts, United States
Funding Status:
Private